Your browser doesn't support javascript.
loading
A Response to: Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis".
Ismaila, Afisi S; Haeussler, Katrin; Malmenäs, Mia; Sharma, Raj; Compton, Chris; Vogelmeier, Claus F; Han, MeiLan K; Halpin, David M G.
Afiliação
  • Ismaila AS; Value Evidence and Outcomes, GSK, 1250 South Collegeville Road, Collegeville, PA, 19426-0989, USA. afisi.s.ismaila@gsk.com.
  • Haeussler K; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada. afisi.s.ismaila@gsk.com.
  • Malmenäs M; ICON Health Economics, ICON Plc., Munich, Germany.
  • Sharma R; ICON Health Economics, ICON Plc., Stockholm, Sweden.
  • Compton C; Value Evidence and Outcomes, R&D Global Medical, GSK, Brentford, UK.
  • Vogelmeier CF; Value Evidence and Outcomes, R&D Global Medical, GSK, Brentford, UK.
  • Han MK; Department of Medicine, Pulmonary and Critical Care Medicine, Philipps-Universität Marburg, Member of the German Center for Lung Research (DZL), Marburg, Germany.
  • Halpin DMG; German Center for Lung Research (DZL), Marburg, Germany.
Adv Ther ; 40(5): 2556-2561, 2023 05.
Article em En | MEDLINE | ID: mdl-37004642

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Androstadienos Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Androstadienos Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article